TechNavio today launched its report Global Vaccine Market 2010“2014 based on an in-depth study focusing exclusively on the Americas and the EMEA and APAC regions. The report aids decision makers™ understanding of the present and the future landscape of this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, There has been significant increase in licensing and co-development agreements in the Global Vaccines market. Here, technologies and development platforms are being shared among small players and global vaccine manufacturers. Smaller vaccine vendors that do not have high financial strength try to generate revenues through royalties and through other revenue sharing agreements.
According to the report, the Global Vaccine market in North America and in Europe is becoming saturated. As a result, many companies are focusing on expanding into other regions. Emerging and developing countries represent a significant opportunity for vaccine manufacturers mainly because of a large unmet medical need of patients for basic vaccines. Further, the report also discusses the challenges of selling basic vaccines in developed countries.
The contents of this report are based on research conducted on an objective combination of primary and secondary scores, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-vaccine-market-2010-2014
Follow us on Twitter @Technavio
TechNavio Announces the Publication of its Report “ Global Vaccine Market 2010“2014
